SG11201602061YA - Novel antibody purification method and antibody obtained therefrom, and novel antibody purification method using cation exchanger and antibody obtained therefrom - Google Patents

Novel antibody purification method and antibody obtained therefrom, and novel antibody purification method using cation exchanger and antibody obtained therefrom

Info

Publication number
SG11201602061YA
SG11201602061YA SG11201602061YA SG11201602061YA SG11201602061YA SG 11201602061Y A SG11201602061Y A SG 11201602061YA SG 11201602061Y A SG11201602061Y A SG 11201602061YA SG 11201602061Y A SG11201602061Y A SG 11201602061YA SG 11201602061Y A SG11201602061Y A SG 11201602061YA
Authority
SG
Singapore
Prior art keywords
antibody
purification method
obtained therefrom
novel
antibody obtained
Prior art date
Application number
SG11201602061YA
Inventor
Kazunobu Minakuchi
Original Assignee
Kaneka Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaneka Corp filed Critical Kaneka Corp
Publication of SG11201602061YA publication Critical patent/SG11201602061YA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1271—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Micrococcaceae (F), e.g. Staphylococcus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55—Fab or Fab'
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/626—Diabody or triabody

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SG11201602061YA 2013-09-17 2014-09-16 Novel antibody purification method and antibody obtained therefrom, and novel antibody purification method using cation exchanger and antibody obtained therefrom SG11201602061YA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2013192379 2013-09-17
JP2013192378 2013-09-17
PCT/JP2014/074452 WO2015041218A1 (en) 2013-09-17 2014-09-16 Novel antibody purification method and antibody obtained therefrom, and novel antibody purification method using cation exchanger and antibody obtained therefrom

Publications (1)

Publication Number Publication Date
SG11201602061YA true SG11201602061YA (en) 2016-04-28

Family

ID=52688867

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201602061YA SG11201602061YA (en) 2013-09-17 2014-09-16 Novel antibody purification method and antibody obtained therefrom, and novel antibody purification method using cation exchanger and antibody obtained therefrom

Country Status (7)

Country Link
US (1) US10519195B2 (en)
EP (1) EP3048109A4 (en)
JP (2) JPWO2015041218A1 (en)
KR (1) KR20160054597A (en)
CN (1) CN105555795A (en)
SG (1) SG11201602061YA (en)
WO (1) WO2015041218A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6663360B2 (en) 2015-01-26 2020-03-11 株式会社カネカ Mutant immunoglobulin kappa chain variable region binding peptide
WO2016121701A1 (en) 2015-01-26 2016-08-04 株式会社カネカ AFFINITY SEPARATION MATRIX FOR PURIFYING PROTEIN CONTAINING IMMUNOGLOBULIN κ CHAIN VARIABLE REGION
JP6709024B2 (en) * 2015-07-03 2020-06-10 国立研究開発法人医薬基盤・健康・栄養研究所 Peptide or protein fractionation method
JP7084301B2 (en) * 2015-08-21 2022-06-14 エフ．ホフマン－ラ ロシュ アーゲー Affinity chromatography purification method using low conductivity wash buffer
EP3367093B1 (en) * 2015-10-23 2021-11-03 FUJIFILM Corporation Affinity chromatography carrier and its use in a biological substance purification method
JP6737579B2 (en) * 2015-10-30 2020-08-12 Jsr株式会社 Affinity chromatography carrier, chromatography column, purification method, and target substance purified by the method
WO2017191747A1 (en) * 2016-05-06 2017-11-09 株式会社カネカ Method for producing protein including κ chain variable region
WO2017195638A1 (en) 2016-05-09 2017-11-16 株式会社カネカ Method for refining antibody or antibody fragment containing κ-chain variable region
WO2019039545A1 (en) 2017-08-23 2019-02-28 Jsr株式会社 Chromatography carrier, ligand-immobilizing carrier, chromatography column, target substance purification method, and chromatography carrier production method
JP7367694B2 (en) 2018-11-06 2023-10-24 Jsr株式会社 Method for producing an organic sulfur compound, carrier, method for producing the carrier, ligand-immobilized carrier, chromatography column, and method for detecting or isolating a target substance
JP7154414B2 (en) * 2019-07-02 2022-10-17 日本メジフィジックス株式会社 Method for Purifying 226Ra-Containing Solution, Method for Producing 226Ra Target, and Method for Producing 225Ac
JPWO2022202467A1 (en) 2021-03-25 2022-09-29
US20240116027A1 (en) 2021-03-25 2024-04-11 Jsr Corporation Method for producing chromatography carrier, method for producing chromatography column, and chromatography carrier
WO2023058409A1 (en) 2021-10-05 2023-04-13 Jsr株式会社 Method for filling column with chromatography carrier, method for storing slurry, and slurry

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3932557A (en) 1972-12-19 1976-01-13 Gulf Research & Development Company Reactive hydrophilic epoxy containing polymer
US4145366A (en) * 1974-11-18 1979-03-20 Teijin Limited Process for isomerizing one of the geometric isomers of an α,β-unsaturated aldehyde to its corresponding other geometric isomer
US4210723A (en) 1976-07-23 1980-07-01 The Dow Chemical Company Method of coupling a protein to an epoxylated latex
US4772653A (en) 1985-11-08 1988-09-20 Amoco Corporation Stain resistant cookware from blends comprising an interpolymer of an unsaturated dicarboxylic acid compound
US5260373A (en) 1987-03-13 1993-11-09 Repligen Corporation Immobilized immunoglobulin-binding proteins
SE467308B (en) 1990-10-22 1992-06-29 Berol Nobel Ab SOLID SURFACE COATED WITH A HYDROPHILIC SURFACE WITH COVALENTLY BONDED BIOPOLYMERS, SET TO MAKE SUCH A SURFACE AND CONJUGATED THEREOF
JPH05202098A (en) 1992-01-29 1993-08-10 Snow Brand Milk Prod Co Ltd Production of physiologically active substance from lactic material
JPH06228200A (en) 1993-01-29 1994-08-16 Snow Brand Milk Prod Co Ltd Production of complement c3c
SE9503925D0 (en) 1995-11-07 1995-11-07 Pharmacia Biotech Ab Separation medium for IgG
US5874165A (en) 1996-06-03 1999-02-23 Gore Enterprise Holdings, Inc. Materials and method for the immobilization of bioactive species onto polymeric subtrates
DE69936946T2 (en) * 1998-05-06 2008-05-15 Genentech, Inc., South San Francisco Purification of antibodies by ion exchange chromatography
US20040224338A1 (en) 1998-08-12 2004-11-11 Zycos Inc., A Delaware Corporation Profiling and cataloging expressed protein tags
WO2000009654A2 (en) 1998-08-12 2000-02-24 Zycos Inc. Profiling and cataloging expressed protein tags
US7709209B2 (en) 2002-03-25 2010-05-04 Ge Healthcare Bio-Sciences Ab Protein ligands
SE0200943D0 (en) 2002-03-25 2002-03-25 Amersham Biosciences Ab Mutant protein
ITMI20020729A1 (en) 2002-04-08 2003-10-08 Resindion S R L SUPPORTS FOR THE COVALENT IMMOBILIZATION OF ENZYMES
ES2214136B1 (en) 2003-02-21 2007-05-16 Consejo Sup. De Invest. Cientificas. NEW IMMOBILIZATION METHOD OF ENZYMES AND OTHER BIO-MACROMOLECULES ON SUPPORTS ACTIVATED WITH EPOXIDE GROUPS CONTAINING IONIZED GROUPS IN THE SPACER ARM THAT JOINS EACH EPOXIDE GROUP TO THE SUPPORT SURFACE.
GB0304576D0 (en) * 2003-02-28 2003-04-02 Lonza Biologics Plc Protein a chromatography
SE0400501D0 (en) 2004-02-27 2004-02-27 Amersham Biosciences Ab Antibody purification
WO2005082483A1 (en) 2004-02-27 2005-09-09 Ge Healthcare Bio-Sciences Ab A process for the purification of antibodies
SE0400886D0 (en) * 2004-04-02 2004-04-02 Amersham Biosciences Ab Process of purification
US8163563B2 (en) 2004-06-09 2012-04-24 Pathogen Removal And Diagnostic Technologies, Inc. Devices and methods for removing target agents from a sample
WO2006043895A1 (en) 2004-10-21 2006-04-27 Ge Healthcare Bio-Sciences Ab A method of antibody purification
US9266041B2 (en) 2004-10-21 2016-02-23 Ge Healthcare Bio-Sciences Ab Chromatography ligand
NZ562949A (en) 2005-04-11 2009-05-31 Medarex Inc Protein purification using HCIC and ion exchange chromatography
TWI391399B (en) 2005-05-25 2013-04-01 Hoffmann La Roche Method for determining the concentration of a salt for eluting a polypeptide
EP1974215B1 (en) * 2006-01-06 2017-12-27 EMD Millipore Corporation Affinity chromatography matrices and methods of making and using the same
US20100234577A1 (en) 2006-06-14 2010-09-16 Smithkline Beecham Corporation Methods for purifying antibodies using ceramic hydroxyapatite
JP5448825B2 (en) 2006-10-19 2014-03-19 ヤンセン バイオテツク，インコーポレーテツド Method for producing non-aggregated antibody Fc domain
WO2008085988A1 (en) 2007-01-05 2008-07-17 Amgen Inc. Methods of purifying proteins
US7999085B2 (en) 2007-01-09 2011-08-16 Bio-Rad Laboratories, Inc. Enhanced capacity and purification of protein by mixed mode chromatography in the presence of aqueous-soluble nonionic organic polymers
US7691980B2 (en) 2007-01-09 2010-04-06 Bio-Rad Laboratories, Inc. Enhanced capacity and purification of antibodies by mixed mode chromatography in the presence of aqueous-soluble nonionic organic polymers
US9433922B2 (en) 2007-08-14 2016-09-06 Emd Millipore Corporation Media for membrane ion exchange chromatography based on polymeric primary amines, sorption device containing that media, and chromatography scheme and purification method using the same
WO2009058769A1 (en) * 2007-10-30 2009-05-07 Schering Corporation Purification of antibodies containing hydrophobic variants
WO2009126603A1 (en) 2008-04-08 2009-10-15 Bio-Rad Laboratories, Inc. Chromatography purification of antibodies
CN102027010A (en) * 2008-05-15 2011-04-20 诺沃-诺迪斯克有限公司 Antibody purification process
CA2733782A1 (en) 2008-08-14 2010-02-18 Merck Sharp & Dohme Corp. Methods for purifying antibodies using protein a affinity chromatography
SG10201702922VA (en) 2008-10-20 2017-06-29 Abbvie Inc Isolation and purification of antibodies using protein a affinity chromatography
JP2010133734A (en) 2008-12-02 2010-06-17 Tosoh Corp Carboxylation carrier for affinity chromatography, and separating agent for affinity chromatography using the same
JP2010133733A (en) 2008-12-02 2010-06-17 Tosoh Corp Cation exchanger, method for manufacturing the same and application thereof
US8497358B2 (en) 2008-12-19 2013-07-30 Takeda Pharmaceutical Company Limited Antibody purification method
US9676845B2 (en) * 2009-06-16 2017-06-13 Hoffmann-La Roche, Inc. Bispecific antigen binding proteins
CN102574911B (en) * 2009-08-07 2017-06-06 Emd密理博公司 The method of target protein from one or more impurity of sample
US9527010B2 (en) * 2009-09-25 2016-12-27 Ge Healthcare Bio-Sciences Corp. Separation system and method
CN104744560A (en) 2009-10-20 2015-07-01 Abbvie公司 Isolation and purification of anti-il-13 antibodies using protein affinity chromatography
US8277649B2 (en) 2009-12-14 2012-10-02 General Electric Company Membranes and associated methods for purification of antibodies
CN102844432A (en) 2010-03-24 2012-12-26 株式会社钟化 Protein capable of binding specifically to immunoglobulin, and immunoglobulin-binding affinity ligand
KR102027596B1 (en) * 2010-12-06 2019-10-01 타폰 바이오시스템즈, 인코포레이티드 Continuous processing methods for biological products
WO2014034457A1 (en) 2012-09-03 2014-03-06 株式会社カネカ Mix-mode antibody affinity separation matrix and purification method using same, and target molecule
KR102272851B1 (en) * 2013-05-06 2021-07-02 사노피 Continuous multistep process for purifying antibodies

Also Published As

Publication number Publication date
JP2019034963A (en) 2019-03-07
JPWO2015041218A1 (en) 2017-03-02
US10519195B2 (en) 2019-12-31
WO2015041218A1 (en) 2015-03-26
KR20160054597A (en) 2016-05-16
CN105555795A (en) 2016-05-04
EP3048109A4 (en) 2017-04-19
US20160237113A1 (en) 2016-08-18
EP3048109A1 (en) 2016-07-27

Similar Documents

Publication Publication Date Title
HRP20190197T1 (en) Rna purification methods
SG11201602061YA (en) Novel antibody purification method and antibody obtained therefrom, and novel antibody purification method using cation exchanger and antibody obtained therefrom
HK1221908A1 (en) Polyspecificity reagents, methods for their preparation and use (polyspecificity)
IL242408B (en) Continuous multistep process for purifying antibodies
PT3004163T (en) Method for purifying antibody
PL3603794T3 (en) Method for gel patterned surfaces
EP3020688A4 (en) Zeolite production method
EP3006415A4 (en) Method for producing nano-cement, and nano-cement
SG11201505204VA (en) Protein purification process
SG11201505198WA (en) Protein purification methods
IL240753B (en) Methods for purifying antibodies
EP3031777A4 (en) Zeolite, and production method and use therefor
EP2987801A4 (en) Method for purifying antibody protein
EP3060578A4 (en) Antibody purification
EP2985275A4 (en) Beta-hydroxy-beta-methylbutyric acid purification method
EP3009400A4 (en) Lev-type zeolite and production method therefor
GB201315777D0 (en) Novel method
GB2530447B (en) Urea synthesis method
PL3083275T3 (en) Silane-modified silicic acid, method for the production and use thereof
PL2891626T3 (en) Method for purifying difluorophosphate
IL241779A (en) Method for producing protein
IL240161A0 (en) Human antibody specific to human metapneumovirus, or antigen-binding fragment thereof
GB201310151D0 (en) Novel method
HK1226026A1 (en) Transfer/punching process
EP2980582A4 (en) Cation exchanger for liquid chromatography, process for producing same, and use thereof